Nutritional, Metabolic, Endocrine
Conditions
Interventions
Ginger Group (Group 1)
Placebo Group (Group 2)
Sponsors
Faculty of Medicine, Ain Shams University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Newly diagnosed type 2 diabetes mellitus, Glycated hemoglobin (HbA1c) level < 9%, Body Mass Index (BMI) = 30 kg/ m2.
Exclusion criteria
Exclusion criteria: Diabetes duration more than 6 months, HbA1c level = 9%, BMI < 30 kg/ m2, Insulin therapy, Any injectable or oral antidiabetic medication other than metformin, Any acute illnesses at baseline or during the study, Smoking, Consumption of less than 80% of the capsules, Any sensitivity due to ginger consumption reported by the patient or noticed after the outset of the study, Consumption of vitamin, mineral or other nutritional supplements, Consumption of alcohol or narcotic drugs, Pregnancy or lactation, Any thyroid or autoimmune disorder, Ischemic, cardiac or renal diseases, Chronic inflammatory diseases, Peptic ulcer, Regular consumption of ginger or other herbal drugs, Consumption of lipid lowering drugs or oral contraceptive pills.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose, 2hour-postprandial blood glucose, Glycated hemoglobin, Total cholesterol, Triglycerides, Low density lipoprotein cholesterol, High density lipoprotein cholesterol | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting insulin level, Homeostatic model assessment (HOMA2) indices: Insulin resistance (HOMA2 - IR), Insulin sensitivity (HOMA2 - %S), Beta-cell function (HOMA2 - %ß) | — |
Countries
Egypt
Contacts
Public ContactMoustafa Hussein
Senior Resident / National Institute of Diabetes and Endocrinology
Outcome results
None listed